Author:
Ito Masaaki,Mimura Tatsuya,Noma Hidetaka,Inoue Yuji,Kawashima Makoto,Mizuno Yoshinobu,Watanabe Emiko,Mizota Atsushi
Abstract
Purpose:
The protracted coronavirus disease (COVID-19) pandemic has caused an unprecedented global health, social, economic, and psychological crisis. COVID-19 is transmitted via droplets, which include volatile organic compounds (VOCs) emitted by COVID-19 carriers. As a result, medical healthcare workers interacting with COVID-19 patients are at a high risk of infection. In this study, we measured the concentration of total VOCs (TVOCs) in the droplets of patients during conversations.
Methods:
Thirty patients aged 20–88 years were enrolled in this study. The amounts of VOCs, formaldehyde (HCHO), and carbon dioxide (CO2) as surrogate parameters for the patient’s droplets were measured at a distance of 1 m from the patients under the following conditions: 1) no conversation with a mask on, 2) conversation with a mask on, 3) conversation without a mask on, and 4) no conversation without a mask on.
Results:
The average concentrations of TVOCs (mg/m3), HCHO (mg/m3), and CO2 (ppm) were all the lowest before the masked conversation (1.79 ± 1.72, 0.25 ± 0.25, 1193 ± 516), increased during the masked conversation (1.99 ± 1.87, 0.29 ± 0.24, 1288 ± 555), were the highest during the unmasked conversation (3.10 ± 1.86, 0.45 ± 0.28, 1705 ± 729), and decreased to baseline after the unmasked conversation (1.89 ± 1.88, 0.26 ± 0.27, 1191 ± 518, respectively). Variations in TVOC and HCHO concentrations were positively correlated with patient age (TVOC: r = 0.42, p = 0.019 and HCHO: r = 0.47, p = 0.008).
Conclusion:
Wearing a mask reduced the VOC concentrations measured during conversations more than when a mask was not worn. Therefore, wearing a mask can reduce the emission of airborne droplet-derived VOCs and thereby reduce the risk of transmission of unknown patient-derived infections.
Clinical Trial Registration no:
The Clinical Trial Registration no: (UMIN000039595)
Publisher
Bentham Science Publishers Ltd.
Reference43 articles.
1. World Health Organization.
Infection prevention and control of epidemic- and pandemic-prone acute respiratory infections in health care.
2014.
Available From: https://apps.who.int/iris/bitstream/handle/10665/112656/9789241507134_eng.pdf?sequence=1
2. Atkinson J, Chartier Y, Lúcia C, et al.
Natural ventilation for Infection Control in Health-Care Settings WHO Publication/Guidelines.
Geneva: World Health Organization 2009; p.
1.
Available From: https://www.who.int/water_sanitation_health/publications/natural_ventilation/
3. Stetzenbach LD, Buttner MP, Cruz P.
Detection and enumeration of airborne biocontaminants.
Curr Opin Biotechnol
2004;
15
(3)
: 170-4.
4. Wong KC, Leung KS.
Transmission and prevention of occupational infections in orthopaedic surgeons.
J Bone Joint Surg Am
2004;
86
(5)
: 1065-76.
5. Liu J, Liao X, Qian S, et al.
Community transmission of severe acute respiratory syndrome coronavirus 2, Shenzhen, China, 2020.
Emerg Infect Dis
2020;
26
(6)
: 1320-3.